9 nominees · 4 ballot items.
Election of nine directors; Ratification of PwC as independent auditor; Advisory approval of named executive officer compensation (Say on Pay); Approval to increase authorized common stock from 150,000,000 to 300,000,000.
Elect nine directors named in the proxy to serve until the next annual meeting.
Ratify PwC as the independent registered public accounting firm for fiscal year ending December 31, 2026.
Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
This advisory proposal asks shareholders to approve, on a non-binding basis, the overall compensation program of the company’s named executive officers as disclosed in the proxy statement. Management and the Compensation Committee argue that the program is designed to align pay with company performance and retention goals, using a mix of base salary, annual cash incentives and long-term equity awards (including performance-based restricted stock units) targeted around market benchmarks. The board recommends a vote FOR, noting the program's pay-for-performance philosophy, use of Aon benchmarking, and incentives tied to key milestones like NDA submission and approval for cytisinicline. A favorable vote would signal shareholder support for the compensation design, while a significant negative vote would prompt the Compensation Committee to consider changes. The vote is non-binding and will not directly change pay arrangements but will inform the board’s and committee’s future decisions. The proposal’s context includes recent leadership changes, equity-based retention grants, and significant financing activity; these factors may influence holders’ evaluation of the alignment between pay and firm performance.
Approve an amendment to the third amended and restated certificate of incorporation to increase authorized common stock from 150,000,000 shares to 300,000,000 shares.
This management proposal seeks shareholder approval to amend the company's certificate of incorporation to double authorized common shares from 150 million to 300 million. Management frames the amendment as operationally necessary to provide sufficient authorized shares for issuances related to recent financing transactions—specifically to enable issuance upon exercise of common warrants and pre-funded warrants issued in the April 2026 private placement—and to preserve flexibility for future equity compensation, financings or strategic transactions without convening special shareholder meetings. The board recommends a FOR vote, emphasizing the need to avoid being unable to deliver shares, which could constitute a breach of warrant terms, and to reduce transaction costs and timing risks. While management disclaims anti-takeover intent, it acknowledges potential anti-takeover effects generally associated with large increases in authorized shares. Approval requires a majority of votes cast and would be effective upon filing with the Delaware Secretary of State; failure to approve would constrain financing and warrant exercise flexibility and could require a special meeting, potentially exposing the company to penalties under certain warrant agreements. The proposal's materiality is heightened by the company's recent sizable April 2026 private placement and the large number of warrants outstanding, making this a consequential governance and capital-structure decision for shareholders.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | FRANKLIN RESOURCES INC | 4.26% | 4,369,193 | $13M |
| 2 | Propel Bio Management, LLC | 3.69% | 3,786,425 | $11M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.15% | 2,204,714 | $6M |
| 4 | Simplify Asset Management Inc. | 1.15% | 1,184,512 | $3M |
| 5 | MILLENNIUM MANAGEMENT LLC | 1.05% | 1,077,338 | $3M |
| 6 | MARSHALL WACE, LLP | 0.84% | 866,105 | $3M |
| 7 | LPL Financial LLC | 0.71% | 728,448 | $2M |
| 8 | Nantahala Capital Management, LLC | 0.63% | 648,885 | $2M |
| 9 | TWO SIGMA INVESTMENTS, LP | 0.57% | 588,551 | $2M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.49% | 501,372 | $1M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.